SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a massive surge as investors react to a significant earnings beat and raised guidance that validates the company's aggressive turnaround strategy and AI data center growth. The stock's parabolic move has sparked intense community debate, with bulls celebrating a long-awaited comeback while shorts face extreme pressure amidst intense speculation over potential squeezes and institutional rotation into the semiconductor sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to the appointment of a new CEO for the Tanbreez project and a significant consolidation of ownership in the Greenland asset. The community is actively debating the stock's potential as a strategic rare earth supplier, with intense discussion around current short-selling dynamics, squeeze potential, and institutional confidence following the recent capital raise.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging in sympathy with Intel's earnings beat and upbeat guidance, as investors rotate into CPU-focused semiconductor names that are seen as critical infrastructure for the expanding AI data center market. The community is sharply divided between bulls riding the aggressive price momentum and bears sounding alarms over extreme valuation levels and the stock's overbought RSI technical indicators.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is experiencing extreme volatility and heavy retail interest following a major legal victory against Papaya Gaming, where a jury awarded the company hundreds of millions in damages with further potential disgorgements pending. While bulls are anticipating a massive short squeeze similar to past momentum plays, the community remains divided between those expecting a continued rally toward triple digits and skeptics who are wary of potential dilution or difficulties in actualizing the legal settlement.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently at the center of intense volatility as traders debate whether the stock is undergoing a post-squeeze collapse or setting up for another massive reversal. Community sentiment is deeply divided, with many actively trading put options to profit from the rapid downside while others speculate about a potential "dead cat bounce" or the risk of further share dilution.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community rallies around its potential for long-term utility and its increasing alignment with XRP, fueled by anticipation for upcoming industry events. Investors are actively debating the impact of the token's deflationary model while holding strong against volatility, with many optimistic that strategic partnerships and institutional adoption will drive significant growth.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending following the overwhelming shareholder approval of its massive merger with Warner Bros. Discovery, a move seen as a major consolidation in the media industry to better compete with streaming rivals. While many investors are optimistic about the long-term potential of the combined assets and debt reduction, community discussions remain divided due to concerns over regulatory scrutiny, executive compensation packages, and the impact of consolidation on creative talent.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing a sharp rally driven by investor optimism surrounding its strategic pivot into producing in-house AI-focused CPUs to power enterprise data centers. The community is actively debating the stock's valuation and long-term trajectory as it shifts from a traditional licensing model to a direct hardware competitor.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is trending following record-breaking fourth-quarter financial results that significantly exceeded analyst expectations, highlighted by surging revenue and profitability driven by heavy AI infrastructure demand. The community is actively discussing a potential short squeeze due to high short interest, while investors weigh the company's deepening partnership with Dell Technologies against broader market volatility and questions regarding long-term revenue guidance.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending as investors weigh conflicting indicators, including ongoing expansion of U.S. manufacturing facilities and potential IRA credit tailwinds against persistent stock price volatility and institutional short interest. The community is actively debating whether the current market valuation represents a deep-value opportunity or a long-term structural trap while monitoring potential consolidation and project monetization as key catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Avis Budget Group logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

CAR Records Worst Day Since 2006 As ‘Most Structurally Violent Short Squeeze Since GameStop’ Unravels

The stock plunged roughly 38% on Wednesday — from a 52-week high near $847 to close around $444 — and continued selling heavily on Thursday to close 48% lower.  

Equity

The stock plunged roughly 38% on Wednesday — from a 52-week high near $847 to close around $444 — and continued selling heavily on Thursday to close 48% lower.  


<ul class="summary-bullets"><li>The company stated in a post on X that it will offer $420.69 in cash for Xbox or PlayStation 5 gaming consoles, with the offer valid from April 20 to 22.</li><li>“The Big Short” investor Michael Burry disclosed earlier this month that he had increased his stake in GameStop.</li><li>GameStop CEO Ryan Cohen stated in a January interview with CNBC that the company is eyeing a “very big” deal that could make GameStop worth hundreds of billions of dollars.</li></ul>Shares of GameStop Corp. (GME) rose 5% on Wednesday morning and were on track for their best intraday gains in nearly 10 weeks.GameStop’s shares are currently trading above the stock’s 50-day and 100-day moving averages.<figure class="image"><img src="https://news.stocktwits-cdn.com/GME_jpg_0c6723d61a.webp" alt="GameStop 50 and 100 DMA" width="1377" height="880"><figcaption>Source: TradingView</figcaption></figure>GameStop’s recent surge comes in the backdrop of the company launching a three-day console trade-in offer. The company stated in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/gamestop/status/2046602979772674488">post</a> on X that it will offer $420.69 in cash for Xbox or PlayStation 5 gaming consoles, with the offer valid from April 20 to 22.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits&nbsp;<a href="https://stocktwits.com/symbol/GME">GameStop</a> trended in the ‘bullish’ territory, with message volumes at ‘high’ levels. GME was among the top trending tickers on the platform at the time of writing.One bullish user on the platform stated that they’re still waiting for news of the acquisition.<stembedurl>https://stocktwits.com/jackdarippah/message/651016311</stembedurl>Another user wondered how long it would take for GameStop’s cash on hand to exceed its market capitalization.<stembedurl>https://stocktwits.com/emptytank/message/651006854</stembedurl>GameStop reported during its fourth-quarter (Q4) results that its cash reserves and short-term investments stood at $9.01 billion at the end of January 2026<h2 class="st-heading-2">Burry Increases GameStop Stake</h2>“The Big Short” investor Michael Burry disclosed earlier this month that he had increased his stake in GameStop.“In a market crash, I believe Ryan could move fast to deploy cash, which would be a catalyst, and I do not see much downside from here, as described in Final Stop GameStop. Corporate governance is as good as it gets if one is ok with a benign dictator,” Burry stated in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://michaeljburry.substack.com/p/trading-post-april-10-2026">post</a> on Substack.This comes after Burry announced in January that he had been buying GameStop shares as a long-term investment.<h2 class="st-heading-2">GameStop CEO Cohen Eyes A ‘Very Big’ Deal</h2>GameStop CEO Ryan Cohen stated in a January interview&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2026/01/30/gamestop-ceo-ryan-cohen-targets-consumer-mega-deal.html">with</a> CNBC that the company is eyeing a “very big” deal that could make GameStop worth hundreds of billions of dollars. GameStop’s current market capitalization is around $11.5 billion.“It’s transformational. Not just for GameStop, but ultimately, within the capital markets … this is something that really has never been done before within the history of the capital markets,” Cohen said.During its fourth-quarter (Q4) earnings in March this year, GameStop did not address Cohen’s comments, nor did it state if an acquisition or a deal is currently under consideration.<h2 class="st-heading-2">GameStop’s Mixed Q4</h2>GameStop reported earnings per share (EPS) of $0.49 on revenue of $1.1 billion. Wall Street estimated an EPS of $0.37 on revenue of $1.47 billion, according to Fiscal.ai data.GameStop is expected to report EPS of $0.12 in the first quarter (Q1) on revenue of $700 million, according to Fiscal.ai data.<a href="https://stocktwits.com/symbol/GME">GME stock</a> is up 27% year-to-date, but down 8% over the past 12 months. The iShares Core S&amp;P Mid-Cap ETF (IJH) is up 32% over the past 12 months, while the Vanguard Total Stock Market Index Fund ETF (VTI) is up 35%.The Vanguard Small-Cap Index Fund ETF (VB) is up 37% during this period, while the Vanguard Small-Cap Value Index Fund ETF (VBR) is up 33%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/google-8-gen-tpu-new-ai-agents-take-on-nvidia-openai-anthropic/cZBBtyDReGu">Google Announces 8th Gen TPU, New AI Agents As It Looks To Take On Nvidia, OpenAI, And Anthropic</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The GameStop logo is being displayed on a smartphone with GameStop visible in the background. (Photo by Jonathan Raa/NurPhoto via Getty Images)

GME Stock On Track For Best Intraday Gains In 10 Weeks — Why Are Retail Traders Excited?

GameStop’s recent surge comes in the backdrop of the company launching a three-day console trade-in offer.

<ul class="summary-bullets"><li>For the Aluminum segment core profit, the company expects sequential favorable impacts of approximately $55 million in Q2.</li><li>The company left its 2026 alumina and aluminum production and shipment guidance unchanged.</li><li>For the first quarter, the company reported revenue of $3.193 billion, down from $3.369 billion a year ago, and below an analyst estimate of $3.3 billion.</li></ul> Alcoa Corporation (AA) shares plunged 3% in after-hours trading Thursday after the company said that it expects a negative impact in the second quarter (Q2) on the Alumina segment owing to the ongoing U.S.-Israel war against Iran.The stock closed the regular session flat at $70.41 before sliding sharply after hours.The company said that it expects sequential unfavorable impacts of approximately $15 million in Q2 on the Alumina segment adjusted core profit, owing in part to higher energy prices due to the conflict in the Middle East.However, for the Aluminum segment core profit, the company expects sequential favorable impacts of approximately $55 million, driven by higher shipments, inventory repositioning, and the completed restart of its San Ciprián smelter in Spain, partially offset by lower energy sales.The company left its 2026 guidance unchanged: alumina production 9.7–9.9 million metric tons and shipments 11.8–12.0 million metric tons; aluminum production 2.4–2.6 million metric tons and shipments 2.6–2.8 million metric tons.<h2 class="st-heading-2">Alcoa Corp Q1 Numbers</h2>For the first quarter (Q1), the company reported revenue of $3.193 billion, down from $3.369 billion a year ago, and below an analyst estimate of $3.3 billion, according to data from Fiscal AI.Adjusted earnings per common share came in at $1.40, lower than the $2.15 reported in the corresponding quarter of 2025, and below an analyst estimate of $1.51, owing to shipment delays and lower volumes.While third party alumina shipments decreased 31% in the quarter to 1.6 million metric tons due to seasonally lower first quarter shipments, Middle East conflict, and Cyclone Narelle, total shipments of Aluminum decreased 8% sequentially to 613,000 metric tons, the company said“Our experienced team performed very well managing the impacts from the Middle East conflict and Cyclone Narelle. We delivered a solid quarter excluding shipment timing impacts, which we expect to realize in the second quarter of 2026,” CEO William F. Oplinger said.Alcoa ended the quarter with $1.4 billion in cash and total debt of $2.551 billion.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around AA stock jumped from bearish to neutral territory over the past 24 hours, while message volume increased from low to normal levels.<a href="https://stocktwits.com/symbol/AA">AA stock</a> has gained about 181% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/nio-vs-xpev-vs-li-which-stock-does-wall-street-see-most-upside-for/cZJvDnDRIxT">NIO Vs. LI Vs. XPEV: Which Stock Does Wall Street See Most Upside For?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Alcoa logo is seen displayed on a smartphone screen.

Alcoa Shares Tumble In After-Hours Trading On Negative Alumina Segment Impact From US-Iran War

Alcoa Stocks - The company said that it expects sequential unfavorable impacts of approximately $15 million in Q2 on the Alumina segment adjusted core profit, owing in part to higher energy prices due to the conflict in the Middle East. 

The company said that it expects sequential unfavorable impacts of approximately $15 million in Q2 on the Alumina segment adjusted core profit, owing in part to higher energy prices due to the conflict in the Middle East. 


<ul class="summary-bullets"><li>Health and Human Services Secretary Robert F. Kennedy Jr. said in an X post on Wednesday that the FDA will remove 12 peptides from the category of drug substances with significant safety risks.</li><li>Leerink analyst Michael Cherny views Kennedy’s announcement as a "clear positive" for Hims &amp; Hers.</li><li>The lifting of restrictions would help "fill the growth hole" the company is likely to see from the transition to commercial weight loss products, the analyst said.</li></ul>Shares of Hims &amp; Hers Health (HIMS) closed up12% on Thursday, marking its fourth consecutive day closing in the green, after the U.S. Food and Drug Administration expressed willingness to consider whether compounding pharmacies can manufacture certain peptides.Health and Human Services Secretary Robert F. Kennedy Jr. <a href="https://stocktwits.com/news-articles/markets/equity/why-is-hims-stock-rallying-after-hours/cZJtsDdRIwt">said</a> in an X post on Wednesday that the FDA will remove 12 peptides from the category of drug substances with significant safety risks. The previous categorization prohibited compounding pharmacies from making versions of it.At two meetings starting in July, independent experts at the Pharmacy Compounding Advisory Committee will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence, the Health Secretary said, stoking investor optimism for HIMS being able to sell peptides.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around HIMS stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘low’ to ‘extremely high’ levels. Retail chatter jumped 628% over the past day, according to platform data.A Stocktwits user said that a possible pivot to peptides will have the biggest driver of revenue growth for Hims.<stembedurl>https://www.stocktwits.com/unassuming/message/650512225</stembedurl>Another user said that the stock continues to be undervalued.<stembedurl>https://www.stocktwits.com/myleomylion/message/650511802</stembedurl>A third user said that the stars are aligned for HIMS stock with Trump not wanting to get “in the way of healthcare” and a recent agreement with Novo Nordisk to sell branded GLP-1 therapies instead of compounded treatments. &nbsp;<stembedurl>https://www.stocktwits.com/PickingTickers/message/650502697</stembedurl><h2 class="st-heading-2">Wall Street Weighs In</h2>Leerink analyst Michael Cherny views Kennedy’s announcement as a "clear positive" for Hims &amp; Hers. The lifting of restrictions would help "fill the growth hole" the company is likely to see from the transition to commercial weight loss products, the analyst told investors in a research note. Leerink believes a positive recommendation from the advisory committee would allow Hims &amp; Hers to leverage its existing peptide facility."This would not immediately translate into revenue but would seemingly be a growth avenue that HIMS would push hard on," the firm writes. Leerink has a ‘Market Perform’ rating on Hims &amp; Hers.Bank of America Securities also lifted its price target on Hims to $25 from $21, while maintaining a ‘Neutral’ rating, earlier in the day.<h2 class="st-heading-2">Hims Eyes Peptides</h2>Hims has previously expressed interest in expanding its peptide offerings. In February, the company said that it plans to work on research and development for “future categories like peptides.”“Our medical team believes certain peptide therapies hold meaningful potential in helping Americans live healthier lives, and we are actively exploring how to expand access in a way that will be aligned with FDA guidance and reflects our commitment to consumer safety, transparency, and clinical excellence,” Hims Chief Medical Office Pat Carroll said on Wednesday.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> has gained 1% over the past 12 months despite diving nearly 54% over the past six months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/pbm-stock-on-track-for-best-session-on-report-of-upcoming-executive-order-on-psychedelic-ibogaine/cZJvrazRIDy">PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS). (Photo illustration by Cheng Xin/Getty Images)

HIMS Stock Closes Another Day In The Green — But Retail Sees More Upside

HIMS Stock - Retail traders are convinced that peptides will be the next key revenue driver for the online telehealth and digital pharmacy platform. 

Retail traders are convinced that peptides will be the next key revenue driver for the online telehealth and digital pharmacy platform. 


<ul class="summary-bullets"><li>At two meetings starting in July, independent experts at the Pharmacy Compounding Advisory Committee will rigorously evaluate each substance on its scientific merits, Kennedy said.</li><li>Peptides are a segment that Hims expressed interest in during its last earnings call in February.&nbsp;</li><li>Peptides are frequently utilized in skincare, supplements, and specialized therapeutic treatments.</li></ul>Shares of Hims &amp; Hers Health (HIMS) closed up 14% and edged 11% higher after-hours on Wednesday as the Trump administration contemplates easing the rules around selling peptides.Health and Human Services Secretary Robert F. Kennedy Jr. said in an X post on Wednesday that the U.S. Food and Drug Administration will remove 12 peptides from the category of drug substances with significant safety risks. The previous categorization prohibited compounding pharmacies from making versions of it.<h2 class="st-heading-2">The Rationale</h2>At two meetings starting in July, independent experts at the Pharmacy Compounding Advisory Committee will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence, the Health Secretary said, adding that the action is aimed at regulating access and shifting demand away from the black market. Peptides are a segment that Hims expressed interest in during its last earnings call in February.Following Kennedy’s post, Hims Chief Medical Office Pat Carroll applauded the move.“Our medical team believes certain peptide therapies hold meaningful potential in helping Americans live healthier lives, and we are actively exploring how to expand access in a way that will be aligned with FDA guidance and reflects our commitment to consumer safety, transparency, and clinical excellence,” Carroll said.Peptides are short chains of amino acids, the building blocks of proteins, used primarily to enhance skin health, build muscle, aid in weight loss, and manage medical conditions. They are frequently utilized in skincare, supplements, and specialized therapeutic treatments.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around HIMS stock jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘low’ to ‘high’ levels.A Stocktwits user highlighted the market demand for peptides.<stembedurl>https://www.stocktwits.com/OSheaTrade/message/650417266</stembedurl>Another highlighted the company’s expanding product range and expressed hopes for the stock to rally to $45, and further to $100.<stembedurl>https://www.stocktwits.com/REALAdrian/message/650414976</stembedurl>According to data from Koyfin, three of the 15 analysts covering HIMS rate it ‘Buy’ or higher, while 12 rate it ‘Hold.’ The 12-month average price target on the stock is $24, representing a potential downside of about 1% from last close.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> has lost 18% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/svra-stock-slips-post-market-after-fda-delays-decision-on-pulmonary-therapy/cZJtoosRIwA">SVRA Stock Slips Post-Market After FDA Delays Decision On Pulmonary Therapy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is HIMS Stock Surging More Than 11% After-Hours Today?

Health and Human Services Secretary Robert F. Kennedy Jr. said in an X post on Wednesday that the FDA will remove 12 peptides from the category of drug substances with significant safety risks.

<ul class="summary-bullets"><li>Earlier this week, Anthropic unveiled Claude Managed Agents, a new tool to help developers build their own AI agents 10 times faster.&nbsp;</li><li>UiPath is a software company that provides automation tools for AI agents.&nbsp;</li><li>Meanwhile, retail traders on Stocktwits turned bullish on the stock, dismissing worries over Anthropic’s threat to the agentic AI company.</li></ul>Shares of UiPath Inc. (PATH) slid more than 5.7% on Friday, reaching an intraday 52-week low, as concerns over Anthropic’s agentic artificial intelligence tools announcement spooked markets.The company’s shares slid to $9.28 during trading hours, before closing up slightly at $9.38. The stock continued to decline in after-market hours.Meanwhile, retail traders on Stocktwits turned bullish on the stock, dismissing worries over Anthropic’s threat to the agentic AI company.<h2 class="st-heading-2">What Is Retail Saying?</h2>On Stocktwits, retail sentiment over PATH stock improved from ‘neutral’ to ‘bullish’ over the past 24 hours, while message volumes climbed from ‘low’ to ‘normal’ levels.One bullish user said that the selloff was “fearful and irrational,” adding that software companies like UiPath would integrate with agentic AI. The user added that while it would take time for that realization to impact markets, the payoff would ultimately be big.<stembedurl>https://stocktwits.com/NachoTheBull/message/649848732</stembedurl>Another user said that the company looked extremely “oversold.”<stembedurl>https://stocktwits.com/newguy1219/message/649853336</stembedurl>Another bullish user expressed disappointment that CEO Daniel Dines was not aggressively buying back the stock to improve share price and sentiment.<stembedurl>https://stocktwits.com/DizPlinTrading/message/649798117</stembedurl><h2 class="st-heading-2">What’s The Anthropic Connection?</h2>Earlier this week, Anthropic unveiled Claude Managed Agents, a new hosted service in the Claude Platform to build, deploy, and scale AI agents, making it easier for developers to build their own infrastructure 10 times faster.The company said that it would offer a secure cloud sandbox for executing code, managing long-running tasks, and handling tool orchestration, helping prototypes launch in days rather than months.The announcement, coupled with other launches from Anthropic, have led to deep selloffs in the software industry. UiPath is a software company that provides automation tools for AI agents.<a href="https://stocktwits.com/symbol/PATH/">PATH stock</a> has declined more than 40% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/net-stock-heads-for-worst-drop-in-over-2-years-retail-goes-bottomfishing/cZJ0SLBRItM">NET Stock Heads For Worst Drop In Over 2 Years — Retail Goes Bottomfishing Amid Software Selloff</a>

The UiPath logo is seen displayed on a smartphone screen next to a keyboard. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

PATH Stock Slides To 52-Week Low Amid Anthropic Concerns — Retail Calls Selloff ‘Irrational’

UiPath shares slid to $9.28 during trading hours, before closing up slightly at $9.38. 

<ul class="summary-bullets"><li>In February 2025, Hims &amp; Hers announced the acquisition of a peptide facility in California to meet the growing demand among Americans for personalized healthcare and treatment options.</li><li>An NYT report stated that top leaders at the FDA have reservations about peptides, according to a senior Department of Health and Human Services official.</li><li>On a recent episode of the Joe Rogan podcast, Health and Human Services Secretary Robert F. Kennedy Jr., who oversees the FDA, said he is a “big fan” of peptides.</li></ul>Hims &amp; Hers Health Inc. (HIMS) shares surged on Tuesday morning amid a report stating that the U.S. Food and Drug Administration is moving to lift restrictions on peptides.According to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2026/03/31/health/peptide-ban-fda-rfk-jr.html">report</a> by The New York Times, the FDA is moving to allow compounding pharmacies to manufacture over a dozen injectable peptides&nbsp;that were previously banned due to potential safety risks.This decision would reverse a 2023 ban that resulted in the removal of 14 peptides from a list of products that the FDA allowed compounding pharmacies to produce.<a href="https://stocktwits.com/symbol/HIMS">Shares of Hims &amp; Hers</a>, which provides compounded medications, surged more than 7% in Tuesday morning’s trade.<h2 class="st-heading-2">Top FDA Leaders Have Reservations About Peptides, Says Report</h2>The report added that top leaders at the FDA have reservations about peptides, according to a senior Department of Health and Human Services official. It noted that if the FDA had flagged peptides as being marketed through unproven claims of disease-fighting and cosmetic benefits.In its 2023 notification, the regulator listed several bulk drug substances, including peptides, noting that it had identified “potential significant safety risks” associated with them.<h2 class="st-heading-2">RFK Jr. Says He Is A ‘Big Fan’ Of Peptides</h2>During an episode of the Joe Rogan podcast earlier this month, Secretary of Health and Human Services Robert F. Kennedy Jr. said that he is a “big fan” of peptides. As the HHS secretary, RFK Jr. oversees the FDA.“I’ve used them myself, and used them with really good effect on a couple of injuries,” he said, while adding that during the Biden administration, 19 peptides were “illegally” moved to Category 2 of the Bulk Substances Nominated Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.This category prohibits compounding pharmacies from formulating compounds comprising peptides, RFK Jr. added.“There was huge demand for peptides and a black market came up, and the black market is run by companies that say the peptides are for animal use or research purposes. And that peptide now basically completely replaced the legal market,” he said.<h2 class="st-heading-2">Where Does Hims &amp; Hers Fit In This Case?</h2>Hims &amp; Hers had come&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-sues-hims-hers-permanent-ban-unapproved-compounded-drugs/cZbHzMjR4o2">under fire</a> from regulators and Novo Nordisk AS (NVO) for offering a compounded version of the company’s best-selling weight-loss pill, Wegovy.Novo Nordisk subsequently&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-soars-novo-nordisk-drops-patent-suit-hims-hers-partnership-ozempic/cZdVZe7RIIk">dropped</a> its lawsuit against Hims &amp; Hers and announced a partnership to offer Ozempic and Wegovy at affordable self-pay prices on the telehealth company’s platform.Earlier in February 2025, Hims &amp; Hers announced the acquisition of a peptide facility based in California to address the growing demand from Americans for personalized healthcare and treatment options.“The peptide capabilities made possible through this acquisition position the company in the coming years to explore exciting advances in peptide innovation, including across areas of consumer need such as preventive health, metabolic optimization, cognitive performance, recovery science, and biological resistance,” the company said.<h2 class="st-heading-2">What Are Peptides?</h2>Peptides are short chains of amino acids, the same building blocks that make up proteins, linked together by peptide bonds.Blockbuster weight-loss drugs Ozempic and Wegovy are also peptide medications that use glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity by&nbsp;stimulating insulin secretion.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> is down 39% year-to-date and 33% over the past 12 months. The iShares Core S&amp;P Mid-Cap ETF (IJH) is up 14% over the past 12 months, while the iShares Russell 2000 ETF (IWM) is up 22%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/warren-buffett-sold-apple-shares-too-soon-berkshire/cZEPvVFRIVi">Buffett Says He Sold Apple Shares Too Soon, But Does Not Regret It: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides

This decision would reverse a 2023 ban that resulted in the removal of 14 peptides from a list of products that the FDA allowed compounding pharmacies to produce.

<ul class="summary-bullets"><li>The net proceeds to be received from the sale of common stock offered by the company will be used for general corporate purposes, among other things.&nbsp;</li><li>Avis operates as a vehicle rental operator in North America, Europe, Australasia and other regions, with an average rental fleet of approximately 684,000 vehicles in 2025.&nbsp;</li><li>Morgan Stanley earlier in the month lowered the firm's price target on Avis Budget to $97 from $142 and kept an ‘Equal Weight’ rating on the shares.</li></ul>Avis Budget Group (CAR) shares fell as much as 4% in Friday’s extended hours of trading after the&nbsp;vehicle sharing and rental services provider announced an automatic offering of its common shares.&nbsp;The company is selling its common shares via automatic offering with par value $0.01 per share.The&nbsp;company said that&nbsp;net proceeds from the offering&nbsp;would be used for general corporate purposes, including repayment of indebtedness, acquisitions, additions to working capital, repurchases of common stock, dividends, capital expenditures and investments in the company’s subsidiaries.&nbsp;Net proceeds may be temporarily invested prior to use, the company added.&nbsp;Avis Budget said that to facilitate the offering of the common stock, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of its common stock.&nbsp;<h2 class="st-heading-2">About Avis</h2>Avis operates three globally recognized brands in mobility solutions named as Avis, Budget and Zipcar. It operates as a vehicle rental operator in North America, Europe, Australasia and other regions, with an average rental fleet of approximately 684,000 vehicles in 2025.&nbsp;<h2 class="st-heading-2">Recent Analyst Actions</h2>Morgan Stanley earlier in the month lowered the firm's price target on Avis Budget to $97 from $142 and kept an ‘Equal Weight’ rating on the shares. The firm updated its rental car estimates post Q4, lowering its targets for Avis after what it called "much weaker than expected results and guidance."Deutsche Bank also lowered the firm's price target on Avis Budget to $128 from $148 and kept a ‘Buy’ rating on the shares.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around CAR trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares of CAR have risen 15% so far this year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

A person views trading stocks on a tablet on the last day of the 2025 trading market in Brussels, Belgium, on December 30, 2025.

Avis Budget Stock Tanks After Hours – What’s Driving It Down?

 The company is selling its common shares via automatic offering with par value $0.01 per share.

<ul class="summary-bullets"><li>Its net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter.</li><li>However, adjusted earnings per share of $0.49 for the fourth quarter ended January 31, 2026, easily surpassed Wall Street consensus of $0.37 as per Stocktwits data.</li></ul>GameStop (<a href="https://stocktwits.com/symbol/GME">GME</a>) shares fell as much as 5% during Tuesday’s extended hours of trading after the video game retailer reported its fourth quarter earnings.&nbsp;The company reported a decline in its fourth quarter net sales. Its net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Analysts on average expected net sales of $1.47 billion, according to data from Stocktwits.&nbsp;<h2 class="st-heading-2">More Details</h2>The company posted adjusted earnings per share of $0.49 for the fourth quarter ended January 31, 2026, easily surpassing Wall Street consensus of $0.37 as per Stocktwits data.&nbsp;GME reported operating income of $135.2 million for the fourth quarter, compared to $79.8 million in the prior year's fourth quarter.&nbsp;Cash, cash equivalents and marketable securities were $9.0 billion at the close of the quarter compared to $4.8 billion at the close of the prior year's fourth quarter. GME’s Bitcoin and related receivables were valued at $368.4 million at the close of the quarter.<h2 class="st-heading-2">Full Year&nbsp;</h2>The company posted net sales of $3.630 billion for fiscal year 2025, compared to $3.823 billion in fiscal year 2024.&nbsp;GME posted an operating income of $232.1 million for the year, compared to an operating loss of $26.2 million in fiscal year 2024. Its net income was $418.4 million for fiscal year 2025, compared to $131.3 million from the previous year.&nbsp;<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around GME trended in ‘bullish’ territory amid ‘high’ message volume.&nbsp;A Stocktwits user praised the company's earnings and said that GME "straight up crushed EPS”.&nbsp;<stembedurl>https://stocktwits.com/TheNeighborhoodSancho/message/648442142</stembedurl>Shares in the company have jumped 12.6% so far in 2026.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is GameStop Stock Nosediving Today?

The company reported a decline in its fourth quarter net sales that also missed analyst expectations according to data from Stocktwits. 

Current Price	$72.64
Prev Close	$72.64
Open	$72.61
Dividend Yield	N/A
50-Day Moving Average	$69.79
Beta	N/A
Avg. Volume	20.76M
PE Ratio	N/A

52-Week High	$74.03
52-Week Low	$55.68
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

IJH
iShares Core S&P Mid-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IJH News

IJHiShares Core S&P Mid-Cap ETF